0 Comments
0 Shares
461 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Gene Therapy and the Future of the Mitochondrial Disease Therapies MarketGene therapy represents one of the most promising frontiers in mitochondrial disease research. Because many mitochondrial diseases have a defined genetic cause, correcting or compensating for the defective gene could, in principle, address the root of the problem rather than just symptoms. This potential is driving investment and shaping the long-term trajectory of the mitochondrial disease...0 Comments 0 Shares 86 Views 0 Reviews
-
GMP Interleukin Market: Cell and Gene Therapy Drives Demand as Tissue-Engineered Products Gain TractionThe [GMP Interleukin Market] is fundamentally shaped by its key applications, with cell and gene therapy currently holding the largest share. This dominance is driven by the critical need for GMP-grade interleukins as essential media supplements for the ex vivo expansion and differentiation of therapeutic cells, such as T-cells and stem cells . However, the market is witnessing a...0 Comments 0 Shares 502 Views 0 Reviews
-
Strategic Growth Opportunities in the Gene Therapy for Age-Related Macular Degeneration MarketThe ophthalmic gene therapy industry is experiencing significant transformation as innovative genetic treatments offer new hope for patients with age-related macular degeneration. The Gene Therapy for Age-Related Macular Degeneration Market is valued at USD 1 billion in 2025 and projected to reach USD 5 billion by 2035 at a CAGR of 13.1%. This article explores strategic growth...0 Comments 0 Shares 337 Views 0 Reviews
-
What Is Driving the Gene Therapy For Age-Related Macular Degeneration Market Growth?Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults, affecting millions of people worldwide. AMD is characterized by degeneration of the macula, the central portion of the retina responsible for sharp, detailed vision. Current treatments for AMD require frequent injections, which are burdensome for patients and healthcare systems. Gene therapy for AMD is...0 Comments 0 Shares 197 Views 0 Reviews
-
APAC Cell and Gene Therapy Market: Growth Drivers and Competitive LandscapeMarket Overview The global Regenerative Medicine Market was valued at USD 31.7 billion in 2025 and is projected to reach USD 218.6 billion by 2035, registering a CAGR of 21.3% during 2025–2035. Regenerative medicine focuses on repairing, replacing, or regenerating damaged cells, tissues, and organs to restore biological function. The market includes cell therapy, gene therapy, tissue...0 Comments 0 Shares 94 Views 0 Reviews
-
APAC Gene Therapy Market: Advances in Genetic Medicine and Ultra-Rare Disease TreatmentsMarket Overview The global Gene Therapy for Ultra-Rare Diseases Market is gaining attention as advances in genetic medicine create new possibilities for treating rare inherited conditions that often have limited treatment options. One published market estimate values this specialized market at USD 0.3 billion in 2025 and projects it to reach USD 0.7 billion by 2035, representing a CAGR of 8.4%...0 Comments 0 Shares 91 Views 0 Reviews
-
Biopharmaceutical Outsourcing: The Future of Cell and Gene Therapy ManufacturingThe development and manufacturing of cell and gene therapies have been revolutionized by the emergence of contract development and manufacturing organizations (CDMOs), which provide specialized expertise and infrastructure for the production of these complex therapies. Biopharmaceutical outsourcing enables companies to access the capabilities needed to bring innovative treatments to market,...0 Comments 0 Shares 579 Views 0 Reviews
-
Cancer Gene Therapy Market Size, Emerging Trends, and Forecast 2033According to the latest report published by Data Bridge Market Research, the Cancer Gene Therapy Market Global cancer gene therapy market size was valued at USD 2.28 billion in 2024 and is projected to reach USD 4.79 billion by 2032, with a CAGR of 9.70% during the forecast period of 2025 to 2032. DBMR team is focused on understanding client’s business and their needs so that the...0 Comments 0 Shares 92 Views 0 Reviews
-
Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share, Growth and Forecast 2034In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Comments 0 Shares 969 Views 0 Reviews
-
Cell & Gene Therapy Contract Research Organizations Market Competitive Landscape and Future GrowthMarket Overview Polaris Market Research’s latest research report, titled Cell & Gene Therapy Contract Research Organizations Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies,...0 Comments 0 Shares 1K Views 0 Reviews
-
Cell and Gene Therapy CDMO: The Future of Gene Therapy ManufacturingThe development and manufacturing of gene therapies have been revolutionized by the emergence of contract development and manufacturing organizations (CDMOs), which provide specialized expertise and infrastructure for vector production. Cell and gene therapy CDMOs enable biopharmaceutical companies to access the capabilities needed to bring gene therapies to market, accelerating the translation...0 Comments 0 Shares 446 Views 0 Reviews
-
Cell and Gene Therapy Clinical Trials Market Growth, Global Trends, Size, Segmentation, Opportunities, Forecast Analysis By Fact.MRRockville, Maryland — October 1, 2026 — The cell and gene therapy clinical trials market is expected to expand from USD 14.3 billion in 2026 to USD 61.5 billion by 2036, advancing at a 15.7% CAGR over the forecast period. The market is being shaped by increasing clinical development activity, rising investment in advanced therapies, expanding healthcare infrastructure, and growing...0 Comments 0 Shares 718 Views 0 Reviews
-
Cell and Gene Therapy Manufacturing Market Future Scope, Regulatory Windows and Forecast to 2033A new report titled “Global Cell and Gene Therapy Manufacturing Market Professional Report 2025-2033” has been added by Straits Research to its repository of research reports. The report analyzes and estimates the market on a global, regional, and country level. The report offers data from previous years along with an in-depth analysis from 2025 to 2033 on the basis of revenue (USD...0 Comments 0 Shares 2K Views 0 Reviews
-
Cell and Gene Therapy Thawing Equipment Market: Technological Advancements and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Cell and Gene Therapy Thawing Equipment Market The global cell and gene therapy thawing equipment market size was valued at USD 940.57 million in 2024 and is expected to reach USD 2,720.95 million by 2032, at a CAGR of 14.20% during the forecast period Cell and Gene Therapy Thawing Equipment...0 Comments 0 Shares 35 Views 0 Reviews
-
DNA Read Write and Edit Market – Genomic Engineering Tools Advancing Synthetic BiologyMarket Overview The DNA read write and edit market is expanding as genomic engineering capabilities converge into integrated platforms supporting sequencing, synthesis, and precision gene editing within unified workflows. This convergence is accelerating synthetic biology research, therapeutic gene editing development, and industrial biotechnology applications that require iterative...0 Comments 0 Shares 407 Views 0 Reviews
-
Exosomes Market to Reach USD 912.33 Million by 2033, Growing at 14.7% CAGRThe global exosomes market size was valued at USD 265.51 million in 2024 and is anticipated to grow from USD 304.54 million in 2025 to reach USD 912.33 million in 2033, growing at a CAGR of 14.7% during the forecast period (2025–2033). According to Straits Research, this report provides a clear understanding of the Exosomes Market by analyzing its overall structure, key...0 Comments 0 Shares 5K Views 0 Reviews
-
Fermenters and Bioreactors Market: The Role of Biologics, Biosimilars, and Cell TherapyFermenters and Bioreactors Market: Growth, Trends, and Forecast to 2034 Overview The global Fermenters and Bioreactors Market was valued at USD 22.28 billion in 2026 and is projected to reach USD 49.17 billion by 2034, registering a CAGR of 10.4% during the forecast period. Market growth is driven by the expansion of biopharmaceutical manufacturing, rising demand for biologics and...0 Comments 0 Shares 639 Views 0 Reviews
-
Gene Therapy in CNS Disorder Market – Vector-Based Innovation Targeting Neurological DiseaseMarket Overview The gene therapy in CNS disorder market is expanding as vector-based delivery innovations increasingly enable direct genetic intervention for neurological conditions previously considered intractable. Advances in adeno-associated virus vector engineering and improved blood-brain barrier delivery strategies are opening therapeutic possibilities for rare pediatric neurological...0 Comments 0 Shares 340 Views 0 Reviews
-
Gene Therapy Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook" According to the latest report published by Data Bridge Market Research, the Gene Therapy Market The global gene therapy market size was valued at USD 10.26 billion in 2024 and is expected to reach USD 39.38 billion by 2032, at a CAGR of 18.30% during the forecast periodThe market growth is largely fueled by the growing demand for curative therapies and rising investments in gene...0 Comments 0 Shares 380 Views 0 Reviews
More Results